Records containing: Hemophilia A
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-12-14ClinicalTrials.gov study NCT00005309
-
CLINICAL_TRIALS study record update · 2018-12-06A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2018-11-23An Open-Label, Multicenter Evaluation of the Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor VIII Fusion Protein (rFVIIIFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia A
-
CLINICAL_TRIALS study record update · 2018-11-14A Randomized, Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Patients Without Inhibitors
-
CLINICAL_TRIALS study record update · 2018-10-18A Phase 1, First in Man, Multicenter, Open Label, Single Escalating Dose Study of BAY1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-09-27Evaluation of Patient and Physician Reported Reasons for Switching FVIII Replacement Therapies
-
CLINICAL_TRIALS study record update · 2018-09-25A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
-
CLINICAL_TRIALS study record update · 2018-09-25Non Interventional Longitudinal Study To Assess The Acceptability And The Satisfaction Of Patients With Haemophilia A Treated Both On Demand And On Prophylaxis With A New Factor Viii Delivery System Fusengo
-
CLINICAL_TRIALS study record update · 2018-09-20A Phase 1, Prospective, Open Label, Two Period, Fixed Sequence, Dose-Escalation Study of the PK and Safety of BAX 826 (PSA-rFVIII) in Previously Treated Patients With Severe (FVIII <1%) Hemophilia A
-
CLINICAL_TRIALS study record update · 2018-09-07An Open-label Phase 1 Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose Administration in Two Cohorts of Previously Treated Male Subjects With Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2018-09-04Evaluation of Real World Outcomes With Extended Half-Life Concentrates for Routine Clinical Use in Haemophilia A and B: UK - EHL Outcomes Registry
-
CLINICAL_TRIALS study record update · 2018-07-17Pharmacovigilance Evaluation Of Refacto Af (Registered) In Germany And Austria
-
CLINICAL_TRIALS study record update · 2018-07-16Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
-
CLINICAL_TRIALS study record update · 2018-06-20Prospective, Observational, 2-cohort Study of Adult Patients With Severe Hemophilia A in Greece. Cost,Clinical Outcomes and Quality of Life Comparison Between on Demand and Secondary Prophylaxis Treatment Strategies
-
CLINICAL_TRIALS study record update · 2018-06-06Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World: The Sao Paulo - Toronto Hemophilia Study
-
CLINICAL_TRIALS study record update · 2018-05-14A Phase 3, Multi-Center, Open Label Study of Efficacy and Safety of PEGylated rFVIII (BAX 855) in Previously Treated Patients With Severe Hemophilia A Undergoing Surgical or Other Invasive Procedures
-
CLINICAL_TRIALS study record update · 2018-04-25A Feasibility and Usability Study of a Nursing Orchestrated, Customized 3 Dimensional Virtual Reality Environment in Children With Hemophilia Undergoing Routine Intravenous Procedures
-
CLINICAL_TRIALS study record update · 2018-03-29An Open-Label, Multicenter, Expanded Access Program for Emicizumab in Patients With Hemophilia A With Inhibitors
-
CLINICAL_TRIALS study record update · 2018-02-22UK-PK Study: National Study of the Implementation of a Pharmacokinetic-Focused Educational Package for Patients Living With Severe Haemophilia A
-
CLINICAL_TRIALS study record update · 2018-02-01Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A
-
CLINICAL_TRIALS study record update · 2018-01-03Development and Evaluation of an Internet-based Educational Program to Promote Self- Management for Teens With Hemophilia
-
CLINICAL_TRIALS study record update · 2017-11-24A Randomized, Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Patients With Inhibitors
-
CLINICAL_TRIALS study record update · 2017-10-03A Multicentre, Interventional, Non-randomized, Open-label, Single-group Phase III Study to Evaluate Plasma-Derived Antihaemophilic Factor/Von Willebrand Factor Concentrate (Biostate®) for Immune Tolerance Induction in Male Paediatric Subjects With Haemophilia A (≤ 2%) Who Have Developed High-titre Antibodies to Factor VIII (Factor VIII Inhibitors)
-
CLINICAL_TRIALS study record update · 2017-09-18Comparison of Ideal vs. Actual Weight Base Factor Dosing
-
CLINICAL_TRIALS study record update · 2017-08-24A Phase III, Open-Label, Multicentre Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Biostate® in Paediatric Subjects With Haemophilia A